Current trends in quantitative proteomics - an update.

Proteins can provide insights into biological processes at the functional level, so they are very promising biomarker candidates. The quantification of proteins in biological samples has been routinely used for the diagnosis of diseases and monitoring the treatment. Although large-scale protein quantification in complex samples is still a challenging task, a great amount of effort has been made to advance the technologies that enable quantitative proteomics. Seven years ago, in 2009, we wrote an article about the current trends in quantitative proteomics. In writing this current paper, we realized that, today, we have an even wider selection of potential tools for quantitative proteomics. These tools include new derivatization reagents, novel sampling formats, new types of analyzers and scanning techniques, and recently developed software to assist in assay development and data analysis. In this review article, we will discuss these innovative methods, and their current and potential applications in proteomics. Copyright © 2017 John Wiley & Sons, Ltd.

[1]  C. Borchers,et al.  Affinity-mass spectrometric technologies for quantitative proteomics in biological fluids , 2017, bioRxiv.

[2]  Jennifer A Mead,et al.  MRMaid, the Web-based Tool for Designing Multiple Reaction Monitoring (MRM) Transitions* , 2009, Molecular & Cellular Proteomics.

[3]  Pei Wang,et al.  A targeted proteomics–based pipeline for verification of biomarkers in plasma , 2011, Nature Biotechnology.

[4]  H. Rodriguez,et al.  Mass spectrometry‐based targeted quantitative proteomics: Achieving sensitive and reproducible detection of proteins , 2012, Proteomics.

[5]  R. Aebersold,et al.  Perspectives of targeted mass spectrometry for protein biomarker verification. , 2009, Current opinion in chemical biology.

[6]  T. Tomonaga,et al.  Absolute quantitation of low abundance plasma APL1β peptides at sub-fmol/mL Level by SRM/MRM without immunoaffinity enrichment. , 2014, Journal of proteome research.

[7]  Gennifer E. Merrihew,et al.  Deconvolution of mixture spectra from ion-trap data-independent-acquisition tandem mass spectrometry. , 2010, Analytical chemistry.

[8]  Hasmik Keshishian,et al.  Automated Microchromatography Enables Multiplexing of Immunoaffinity Enrichment of Peptides to Greater than 150 for Targeted MS-Based Assays. , 2016, Analytical chemistry.

[9]  C. Perou,et al.  Development of an immuno tandem mass spectrometry (iMALDI) assay for EGFR diagnosis , 2007, Proteomics. Clinical applications.

[10]  S. Carr,et al.  Targeted MS Assay Predicting Tamoxifen Resistance in Estrogen-Receptor-Positive Breast Cancer Tissues and Sera. , 2016, Journal of proteome research.

[11]  Scott A. Shaffer,et al.  A novel ion funnel for focusing ions at elevated pressure using electrospray ionization mass spectrometry , 1997 .

[12]  S. Hillier,et al.  Newborn blood spot screening for sickle cell disease by using tandem mass spectrometry: implementation of a protocol to identify only the disease states of sickle cell disease. , 2014, Clinical chemistry.

[13]  G. G. Stokes.  "J." , 1890, The New Yale Book of Quotations.

[14]  Bruno Domon,et al.  Large-Scale Targeted Proteomics Using Internal Standard Triggered-Parallel Reaction Monitoring (IS-PRM)* , 2015, Molecular & Cellular Proteomics.

[15]  A. Vlahou,et al.  SRM/MRM targeted proteomics as a tool for biomarker validation and absolute quantification in human urine , 2015, Expert review of molecular diagnostics.

[16]  C. Greenberg,et al.  LC-MS/MS progress in newborn screening. , 2011, Clinical biochemistry.

[17]  Brendan MacLean,et al.  Building high-quality assay libraries for targeted analysis of SWATH MS data , 2015, Nature Protocols.

[18]  Ping Wu,et al.  Quantification of histone modifications by parallel-reaction monitoring: a method validation. , 2015, Analytical chemistry.

[19]  S. Fisher,et al.  Breaking the bottleneck in the protein biomarker pipeline. , 2012, Clinical chemistry.

[20]  A. Makarov,et al.  Evolution of Orbitrap Mass Spectrometry Instrumentation. , 2015, Annual review of analytical chemistry.

[21]  M. Mann,et al.  Proteomics on an Orbitrap Benchtop Mass Spectrometer Using All-ion Fragmentation , 2010, Molecular & Cellular Proteomics.

[22]  Christoph H Borchers,et al.  Multiplexed MRM with Internal Standards for Cerebrospinal Fluid Candidate Protein Biomarker Quantitation. , 2014, Journal of proteome research.

[23]  Eric W. Deutsch,et al.  A complete mass-spectrometric map of the yeast proteome applied to quantitative trait analysis , 2013, Nature.

[24]  Heidi Zhang,et al.  Integrated pipeline for mass spectrometry-based discovery and confirmation of biomarkers demonstrated in a mouse model of breast cancer. , 2007, Journal of proteome research.

[25]  S. Lehmann,et al.  Absolute quantification of 35 plasma biomarkers in human saliva using targeted MS. , 2016, Bioanalysis.

[26]  D R Mani,et al.  Simplified and Efficient Quantification of Low-abundance Proteins at Very High Multiplex via Targeted Mass Spectrometry* , 2014, Molecular & Cellular Proteomics.

[27]  Ludovic C. Gillet,et al.  Targeted Data Extraction of the MS/MS Spectra Generated by Data-independent Acquisition: A New Concept for Consistent and Accurate Proteome Analysis* , 2012, Molecular & Cellular Proteomics.

[28]  Luis Mendoza,et al.  PASSEL: The PeptideAtlas SRMexperiment library , 2012, Proteomics.

[29]  Ruedi Aebersold,et al.  On the development of plasma protein biomarkers. , 2011, Journal of proteome research.

[30]  E. Diamandis,et al.  The bottleneck in the cancer biomarker pipeline and protein quantification through mass spectrometry-based approaches: current strategies for candidate verification. , 2010, Clinical chemistry.

[31]  Brendan MacLean,et al.  Bioinformatics Applications Note Gene Expression Skyline: an Open Source Document Editor for Creating and Analyzing Targeted Proteomics Experiments , 2022 .

[32]  C. E. Parker,et al.  Mass-spectrometry-based clinical proteomics--a review and prospective. , 2010, The Analyst.

[33]  Darryl B. Hardie,et al.  Precise quantitation of 136 urinary proteins by LC/MRM-MS using stable isotope labeled peptides as internal standards for biomarker discovery and/or verification studies. , 2015, Methods.

[34]  Pei Wang,et al.  The interface between biomarker discovery and clinical validation: The tar pit of the protein biomarker pipeline , 2008, Proteomics. Clinical applications.

[35]  Yang Xu,et al.  Merck's perspective on the implementation of dried blood spot technology in clinical drug development - why, when and how. , 2013, Bioanalysis.

[36]  Yasset Perez-Riverol,et al.  A multi-center study benchmarks software tools for label-free proteome quantification , 2016, Nature Biotechnology.

[37]  Christoph H Borchers,et al.  Standardized protocols for quality control of MRM-based plasma proteomic workflows. , 2013, Journal of proteome research.

[38]  Christoph H Borchers,et al.  MRM for the verification of cancer biomarker proteins: recent applications to human plasma and serum , 2014, Expert review of proteomics.

[39]  Michael J MacCoss,et al.  Large-Scale Interlaboratory Study to Develop, Analytically Validate and Apply Highly Multiplexed, Quantitative Peptide Assays to Measure Cancer-Relevant Proteins in Plasma* , 2015, Molecular & Cellular Proteomics.

[40]  Juergen Kast,et al.  Implementation of a data repository-driven approach for targeted proteomics experiments by multiple reaction monitoring. , 2009, Journal of proteomics.

[41]  Y. Yu,et al.  Ultra-performance liquid chromatography/tandem mass spectrometry (UPLC/MS/MS) and UPLC/MS(E) analysis of RNA oligonucleotides. , 2010, Rapid communications in mass spectrometry : RCM.

[42]  Andrew J. Percy,et al.  Clinical translation of MS-based, quantitative plasma proteomics: status, challenges, requirements, and potential , 2016, Expert review of proteomics.

[43]  C. Borchers,et al.  Developing an iMALDI method. , 2013, Methods in molecular biology.

[44]  D. Formanowicz,et al.  Deeper insight into chronic kidney disease-related atherosclerosis: comparative proteomic studies of blood plasma using 2DE and mass spectrometry , 2015, Journal of Translational Medicine.

[45]  Luis Mendoza,et al.  MaRiMba: a software application for spectral library-based MRM transition list assembly. , 2009, Journal of proteome research.

[46]  Derek J. Bailey,et al.  Parallel Reaction Monitoring for High Resolution and High Mass Accuracy Quantitative, Targeted Proteomics* , 2012, Molecular & Cellular Proteomics.

[47]  Jarrett D. Egertson,et al.  Multiplexed MS/MS for Improved Data Independent Acquisition , 2013, Nature Methods.

[48]  N. Rauniyar,et al.  Parallel Reaction Monitoring: A Targeted Experiment Performed Using High Resolution and High Mass Accuracy Mass Spectrometry , 2015, International journal of molecular sciences.

[49]  M. Goshe,et al.  Improving protein and proteome coverage through data-independent multiplexed peptide fragmentation. , 2010, Journal of proteome research.

[50]  Christoph H Borchers,et al.  Towards the development of an immuno MALDI (iMALDI) mass spectrometry assay for the diagnosis of hypertension , 2010, Journal of the American Society for Mass Spectrometry.

[51]  Ruedi Aebersold,et al.  System-wide Quantitative Proteomics of the Metabolic Syndrome Blockinin Blockinmice: Blockingenotypic Blockinand Blockindietary Blockineffects , 2022 .

[52]  Josephine Ec Burnett,et al.  Dried blood spot sampling: practical considerations and recommendation for use with preclinical studies. , 2011, Bioanalysis.

[53]  D. Eichner,et al.  Quantification of insulin-like growth factor-1 in dried blood spots for detection of growth hormone abuse in sport , 2013, Analytical and Bioanalytical Chemistry.

[54]  Alexander G. Camenzind,et al.  Quantitation of spatially-localized proteins in tissue samples using MALDI-MRM imaging. , 2012, Analytical chemistry.

[55]  D. Goodlett,et al.  Faster, quantitative, and accurate precursor acquisition independent from ion count. , 2011, Analytical chemistry.

[56]  Bindu Nanduri,et al.  Prediction of peptides observable by mass spectrometry applied at the experimental set level , 2007, BMC Bioinformatics.

[57]  Darryl B. Hardie,et al.  SISCAPA Peptide Enrichment on Magnetic Beads Using an In-line Bead Trap Device*S , 2009, Molecular & Cellular Proteomics.

[58]  Kathryn S Lilley,et al.  Taming the isobaric tagging elephant in the room in quantitative proteomics , 2011, Nature Methods.

[59]  K. Parker,et al.  Multiplexed Protein Quantitation in Saccharomyces cerevisiae Using Amine-reactive Isobaric Tagging Reagents*S , 2004, Molecular & Cellular Proteomics.

[60]  Jörg Grigull,et al.  Endometrial Carcinoma Biomarker Discovery and Verification Using Differentially Tagged Clinical Samples with Multidimensional Liquid Chromatography and Tandem Mass Spectrometry*S , 2007, Molecular & Cellular Proteomics.

[61]  Darryl B. Hardie,et al.  Mass spectrometric quantitation of peptides and proteins using Stable Isotope Standards and Capture by Anti-Peptide Antibodies (SISCAPA). , 2004, Journal of proteome research.

[62]  C. Tian,et al.  Software for quantitative proteomic analysis using stable isotope labeling and data independent acquisition. , 2011, Analytical chemistry.

[63]  B. Domon,et al.  Quantification of proteins in urine samples using targeted mass spectrometry methods. , 2015, Methods in molecular biology.

[64]  Charlotte Sværke Jørgensen,et al.  Non-specific binding in solid phase immunoassays for autoantibodies correlates with inflammation markers. , 2014, Journal of immunological methods.

[65]  Alexander G. Camenzind,et al.  An automated assay for the clinical measurement of plasma renin activity by immuno-MALDI (iMALDI). , 2015, Biochimica et biophysica acta.

[66]  Tao Xu,et al.  Bioinformatics Applications Note Sequence Analysis Xdia: Improving on the Label-free Data-independent Analysis , 2022 .

[67]  C. Bessant,et al.  Free computational resources for designing selected reaction monitoring transitions , 2010, Proteomics.

[68]  S. Carr,et al.  Multiplexed Immunoaffinity Enrichment of Peptides with Anti-peptide Antibodies and Quantification by Stable Isotope Dilution Multiple Reaction Monitoring Mass Spectrometry. , 2016, Methods in molecular biology.

[69]  Oliver M. Bernhardt,et al.  Reproducible and Consistent Quantification of the Saccharomyces cerevisiae Proteome by SWATH-mass spectrometry* , 2015, Molecular & Cellular Proteomics.

[70]  Christoph H Borchers,et al.  Development of MRM-based assays for the absolute quantitation of plasma proteins. , 2013, Methods in molecular biology.

[71]  Monica H. Elliott,et al.  Current trends in quantitative proteomics. , 2009, Journal of mass spectrometry : JMS.

[72]  Alexander Lazarev,et al.  Sample Preparation in Biological Mass Spectrometry , 2011 .

[73]  D R Mani,et al.  Interlaboratory Evaluation of Automated, Multiplexed Peptide Immunoaffinity Enrichment Coupled to Multiple Reaction Monitoring Mass Spectrometry for Quantifying Proteins in Plasma* , 2011, Molecular & Cellular Proteomics.

[74]  Christoph H Borchers,et al.  Multiple Reaction Monitoring-based, Multiplexed, Absolute Quantitation of 45 Proteins in Human Plasma* , 2009, Molecular & Cellular Proteomics.

[75]  R. Caprioli,et al.  Molecular imaging of biological samples: localization of peptides and proteins using MALDI-TOF MS. , 1997, Analytical chemistry.

[76]  Ben C. Collins,et al.  OpenSWATH enables automated, targeted analysis of data-independent acquisition MS data , 2014, Nature Biotechnology.

[77]  N. Anderson,et al.  Quantification of a proteotypic peptide from protein C inhibitor by liquid chromatography-free SISCAPA-MALDI mass spectrometry: application to identification of recurrence of prostate cancer. , 2013, Clinical chemistry.

[78]  Yassene Mohammed,et al.  Qualis-SIS: automated standard curve generation and quality assessment for multiplexed targeted quantitative proteomic experiments with labeled standards. , 2015, Journal of proteome research.

[79]  Mehdi Mirzaei,et al.  Inter-laboratory evaluation of instrument platforms and experimental workflows for quantitative accuracy and reproducibility assessment , 2015 .

[80]  Hasmik Keshishian,et al.  Multiplexed, Quantitative Workflow for Sensitive Biomarker Discovery in Plasma Yields Novel Candidates for Early Myocardial Injury* , 2015, Molecular & Cellular Proteomics.

[81]  M. Mann,et al.  Mass spectrometry–based proteomics turns quantitative , 2005, Nature chemical biology.

[82]  Christoph H Borchers,et al.  Multi-site assessment of the precision and reproducibility of multiple reaction monitoring–based measurements of proteins in plasma , 2009, Nature Biotechnology.

[83]  Andrew J. Percy,et al.  Multiple Reaction Monitoring Enables Precise Quantification of 97 Proteins in Dried Blood Spots* , 2015, Molecular & Cellular Proteomics.

[84]  S. Carr,et al.  A pipeline that integrates the discovery and verification of plasma protein biomarkers reveals candidate markers for cardiovascular disease , 2011, Nature Biotechnology.

[85]  R. Aebersold,et al.  mProphet: automated data processing and statistical validation for large-scale SRM experiments , 2011, Nature Methods.

[86]  G. Jarvik,et al.  Parallel reaction monitoring (PRM) and selected reaction monitoring (SRM) exhibit comparable linearity, dynamic range and precision for targeted quantitative HDL proteomics. , 2015, Journal of proteomics.

[87]  B. Simons,et al.  Performance characteristics of a new hybrid quadrupole time-of-flight tandem mass spectrometer (TripleTOF 5600). , 2011, Analytical chemistry.

[88]  Birgit Schilling,et al.  Interlaboratory Study Characterizing a Yeast Performance Standard for Benchmarking LC-MS Platform Performance* , 2009, Molecular & Cellular Proteomics.

[89]  Christoph H Borchers,et al.  Multiplexed Quantitation of Endogenous Proteins in Dried Blood Spots by Multiple Reaction Monitoring - Mass Spectrometry , 2012, Molecular & Cellular Proteomics.

[90]  Juan P Albar,et al.  Multicenter experiment for quality control of peptide-centric LC-MS/MS analysis - A longitudinal performance assessment with nLC coupled to orbitrap MS analyzers. , 2015, Journal of proteomics.

[91]  Randall W. Nelson,et al.  Parallel Workflow for High-Throughput (>1,000 Samples/Day) Quantitative Analysis of Human Insulin-Like Growth Factor 1 Using Mass Spectrometric Immunoassay , 2014, PloS one.

[92]  Richard D. Smith,et al.  Ionization and transmission efficiency in an electrospray ionization—mass spectrometry interface , 2007, Journal of the American Society for Mass Spectrometry.

[93]  Martin von Bergen,et al.  Comparison of targeted peptide quantification assays for reductive dehalogenases by selective reaction monitoring (SRM) and precursor reaction monitoring (PRM) , 2013, Analytical and Bioanalytical Chemistry.

[94]  C. Borchers,et al.  Comparison of standard- and nano-flow liquid chromatography platforms for MRM-based quantitation of putative plasma biomarker proteins , 2012, Analytical and Bioanalytical Chemistry.

[95]  Rainer Paape,et al.  Precision of heavy-light peptide ratios measured by maldi-tof mass spectrometry. , 2012, Journal of proteome research.

[96]  Daniel B. Martin,et al.  Computational prediction of proteotypic peptides for quantitative proteomics , 2007, Nature Biotechnology.

[97]  H. Rodriguez,et al.  Reconstructing the pipeline by introducing multiplexed multiple reaction monitoring mass spectrometry for cancer biomarker verification: An NCI‐CPTC initiative perspective , 2010, Proteomics. Clinical applications.

[98]  Juncong Yang,et al.  MRM‐based multiplexed quantitation of 67 putative cardiovascular disease biomarkers in human plasma , 2012, Proteomics.

[99]  Susan E. Abbatiello,et al.  Targeted Peptide Measurements in Biology and Medicine: Best Practices for Mass Spectrometry-based Assay Development Using a Fit-for-Purpose Approach* , 2014, Molecular & Cellular Proteomics.

[100]  Christoph H Borchers,et al.  Method and platform standardization in MRM-based quantitative plasma proteomics. , 2013, Journal of proteomics.

[101]  Anatoly I Grigoriev,et al.  Targeted Quantitative Screening of Chromosome 18 Encoded Proteome in Plasma Samples of Astronaut Candidates. , 2016, Journal of proteome research.

[102]  Nichole L. King,et al.  Targeted Quantitative Analysis of Streptococcus pyogenes Virulence Factors by Multiple Reaction Monitoring*S , 2008, Molecular & Cellular Proteomics.

[103]  I. Wilson,et al.  UPLC/MS(E); a new approach for generating molecular fragment information for biomarker structure elucidation. , 2006, Rapid communications in mass spectrometry : RCM.

[104]  Samuel I. Miller,et al.  Precursor acquisition independent from ion count: how to dive deeper into the proteomics ocean. , 2009, Analytical chemistry.

[105]  Dana Pascovici,et al.  SWATH Mass Spectrometry Performance Using Extended Peptide MS/MS Assay Libraries* , 2016, Molecular & Cellular Proteomics.

[106]  T. Colgan,et al.  Absolute quantification of potential cancer markers in clinical tissue homogenates using multiple reaction monitoring on a hybrid triple quadrupole/linear ion trap tandem mass spectrometer. , 2009, Analytical chemistry.

[107]  S. Carr,et al.  Antibody-based capture of target peptides in multiple reaction monitoring experiments. , 2015, Methods in molecular biology.

[108]  C. Borchers,et al.  Increased Depth and Breadth of Plasma Protein Quantitation via Two-Dimensional Liquid Chromatography/Multiple Reaction Monitoring-Mass Spectrometry with Labeled Peptide Standards. , 2016, Methods in molecular biology.

[109]  C. Borchers,et al.  Improving the biomarker pipeline. , 2010, Clinical chemistry.

[110]  D. Eichner,et al.  Sensitive quantification of IGF-1 and its synthetic analogs in dried blood spots. , 2014, Bioanalysis.

[111]  Ruedi Aebersold,et al.  Mass spectrometric protein maps for biomarker discovery and clinical research , 2013, Expert review of molecular diagnostics.

[112]  John D. Venable,et al.  Automated approach for quantitative analysis of complex peptide mixtures from tandem mass spectra , 2004, Nature Methods.

[113]  Christoph H Borchers,et al.  Design, Implementation and Multisite Evaluation of a System Suitability Protocol for the Quantitative Assessment of Instrument Performance in Liquid Chromatography-Multiple Reaction Monitoring-MS (LC-MRM-MS)* , 2013, Molecular & Cellular Proteomics.

[114]  D. Goodlett,et al.  Shotgun collision‐induced dissociation of peptides using a time of flight mass analyzer , 2003, Proteomics.

[115]  Ulf Landegren,et al.  Opportunities for sensitive plasma proteome analysis. , 2012, Analytical chemistry.

[116]  Yassene Mohammed,et al.  PeptidePicker: a scientific workflow with web interface for selecting appropriate peptides for targeted proteomics experiments. , 2014, Journal of proteomics.

[117]  M. Sadílek,et al.  Tryptic peptide analysis of ceruloplasmin in dried blood spots using liquid chromatography-tandem mass spectrometry: application to newborn screening. , 2008, Clinical chemistry.

[118]  C. Borchers,et al.  An immunoaffinity tandem mass spectrometry (iMALDI) assay for detection of Francisella tularensis. , 2007, Analytica chimica acta.

[119]  N. Anderson,et al.  The Human Plasma Proteome , 2002, Molecular & Cellular Proteomics.

[120]  M. Chen,et al.  Bead-Extractor Assisted Ready-to-Use Reagent System (BEARS) for Immunoprecipitation Coupled to MALDI-MS. , 2017, Analytical chemistry.

[121]  R. Aebersold,et al.  Selected reaction monitoring–based proteomics: workflows, potential, pitfalls and future directions , 2012, Nature Methods.

[122]  Lisa M. Chung,et al.  Review of software tools for design and analysis of large scale MRM proteomic datasets. , 2013, Methods.

[123]  Richard D. Smith,et al.  Advances in targeted proteomics and applications to biomedical research , 2016, Proteomics.

[124]  Alexander G. Camenzind,et al.  Duplexed iMALDI for the detection of angiotensin I and angiotensin II. , 2012, Methods.

[125]  B. Keevil.  The analysis of dried blood spot samples using liquid chromatography tandem mass spectrometry. , 2011, Clinical biochemistry.

[126]  S. Gygi,et al.  MS3 eliminates ratio distortion in isobaric labeling-based multiplexed quantitative proteomics , 2011, Nature Methods.

[127]  Thomas J. Wang.  Significance of circulating troponins in heart failure: if these walls could talk. , 2007, Circulation.

[128]  Amanda G. Paulovich,et al.  An Automated and Multiplexed Method for High Throughput Peptide Immunoaffinity Enrichment and Multiple Reaction Monitoring Mass Spectrometry-based Quantification of Protein Biomarkers* , 2009, Molecular & Cellular Proteomics.

[129]  D. Galasko,et al.  Cerebrospinal Fluid Peptides as Potential Parkinson Disease Biomarkers: A Staged Pipeline for Discovery and Validation* , 2015, Molecular & Cellular Proteomics.

[130]  Henry H. N. Lam,et al.  PeptideAtlas: a resource for target selection for emerging targeted proteomics workflows , 2008, EMBO reports.

[131]  C. Borchers,et al.  The use of multiplexed MRM for the discovery of biomarkers to differentiate iron-deficiency anemia from anemia of inflammation. , 2012, Journal of proteomics.

[132]  J. Adamski,et al.  Targeted Metabolomics of Dried Blood Spot Extracts , 2013, Chromatographia.

[133]  James G. Bollinger,et al.  A targeted proteomic strategy for the measurement of oral cancer candidate biomarkers in human saliva , 2016, Proteomics.

[134]  N Leigh Anderson,et al.  High-throughput SISCAPA quantitation of peptides from human plasma digests by ultrafast, liquid chromatography-free mass spectrometry. , 2012, Journal of proteome research.

[135]  J. Yates,et al.  Isobaric Labeling-Based Relative Quantification in Shotgun Proteomics , 2014, Journal of proteome research.

[136]  D. Chace,et al.  Use of tandem mass spectrometry for multianalyte screening of dried blood specimens from newborns. , 2003, Clinical chemistry.

[137]  Matthew J. Rardin,et al.  Multiplexed, Scheduled, High-Resolution Parallel Reaction Monitoring on a Full Scan QqTOF Instrument with Integrated Data-Dependent and Targeted Mass Spectrometric Workflows. , 2015, Analytical chemistry.

[138]  Michael J. Sweredoski,et al.  High resolution parallel reaction monitoring with electron transfer dissociation for middle-down proteomics. , 2015, Analytical chemistry.

[139]  J. Mesirov,et al.  Prediction of high-responding peptides for targeted protein assays by mass spectrometry , 2009, Nature Biotechnology.